INTRODUCTION
============

*Drosophila melanogaster* has been developed as a model system for studying learning and memory because of its short lifespan and the relatively simple and facile nervous system \[[@B1],[@B2]\]. To date, several genes have been identified to be involved in the formation of *Drosophila* olfactory memory \[[@B2]--[@B4]\], but little is known about the genetic basis and mechanisms that contribute to LTM (long-term memory) formation. One *Drosophila* mutant, crammer, exhibits a specific LTM defect \[[@B5],[@B6]\]. The overexpression of crammer in glial cells impairs LTM, suggesting that the expression level of crammer is of functional importance with regard to LTM formation. The crammer gene encodes a cysteine protease inhibitor, and potential targets include cathepsins. The structural properties of crammer are hitherto uncharacterized. Crammer shares approximately 45% primary sequence identity with the proregions of the *Bombyx mori* and *D. melanogaster* cysteine proteases, suggesting that crammer belongs to a class of cysteine protease inhibitors that have propeptide-like inhibitory activity \[[@B7]\]. Such inhibitors, originally identified in mouse-activated T-cells and mast cells, are also known as cytotoxic T-lymphocyte antigen (CTLA) 2α and 2β \[[@B8]\], and they exhibit inhibitory activities against papain and cathepsin L \[[@B9],[@B10]\]. Similar inhibitors have also been identified in other organisms such as *B. mori* \[[@B11]--[@B13]\].

Using yeast two-hybrid assay, a number of crammer-interacting proteins have been identified. These include cathepsins B and L, and capping protein β \[[@B14],[@B15]\]. Cathepsins are synthesized as zymogens, each of which contains an N-terminal proregion and a mature protein sequence. The proregion contains a signal peptide and a propeptide. The propeptide is required for intracellular targeting \[[@B16]\], protein folding \[[@B17]\] and enzyme inhibition \[[@B18]\]. Removal of the propeptide by other proteases \[[@B19],[@B20]\] or by autocleavage at acidic pH \[[@B21]\] activates cathepsins. As the name suggests, inhibition by a propeptide-like protease inhibitor is linked to its sequence and/or structural similarity to the proregion of its target protease. Crammer contains a GNFD motif, GXNX(F/L)XD, which is highly conserved among propeptide-like inhibitors \[[@B13]\] and is found in the proregions of most cysteine proteases \[[@B22]\]. The GNFD motif is essential for auto-activation and protein folding \[[@B22]\], but its inhibitory role by propeptide-like inhibitors is unclear. Crammer also contains a consensus ERFNIN motif, EX~3~RX~3~(F/Y)X~2~(N/S)X~3~IX~3~N, which is essential for protease inhibition \[[@B8],[@B9]\]. Finally, crammer contains a conserved motif at the N-terminus, YKX~4~KXY, which serves as a lysosomal-targeting sequence \[[@B23],[@B24]\], suggesting that crammer is a lysosomal protein.

Despite the biological significance of propeptide-like protease inhibitors, there has hitherto been no structural information available. Although monomeric and dimeric crammer have been reported to inhibit cathepsin \[[@B15]\], the molecular mechanism of its inhibitory mechanism remains elusive. To clarify how the structure of crammer relates to its function, in the present paper we report detailed enzyme kinetic analysis and the solution structure of crammer using heteronuclear NMR spectroscopy. In light of the emerging roles of cathepsins B and L in neurodegenerative diseases \[[@B25]--[@B27]\], understanding the molecular basis of the protease inhibitory activity of crammer will provide valuable insight into the development of treatments for these diseases.

EXPERIMENTAL
============

Materials
---------

ANS (8-anilinonaphthalene-l-sulfonic acid) and E-64 \[*trans*-epoxysuccinyl-[L]{.smallcaps}-leucylamido-(4-guanidino)butane\] were purchased from Sigma--Aldrich. 2-Mercaptoethanol, chloramphenicol and sodium azide were supplied by Merck Research Laboratories. Ampicillin, DTT (dithiothreitol) and IPTG (isopropyl β-[D]{.smallcaps}-thiogalactopyranoside) were obtained from MDBio (Taipei, Taiwan). EDTA and Blue Dextran 2000 were purchased from USB. Glacial acetic acid and Triton X-100 were supplied by ECHO Chemical and Amresco respectively. All chemicals were of analytical grade.

Protein expression and purification
-----------------------------------

A two-step PCR was used to synthesize the crammer gene \[[@B28]\]. The primers were obtained from Mission Biotechnology. The crammer gene was assembled and amplified by PCR \[[@B28]\]. The final product was cloned into a pAED4 vector (Dr Min Lu, Weill Medical College of Cornell University, New York, NY, U.S.A.) and expressed in *Escherichia coli* Rosetta (DE3) strain (Merck). Site-specific point mutations were prepared with the QuikChange site-directed mutagenesis kit (Stratagene) and expressed and purified following the same protocol as described for wild-type crammer. The sequences of the recombinant genes were verified by DNA sequencing (Mission Biotechnology).

*E. coli* cells harbouring pAED4 that contain the crammer or mutant genes were cultured in Luria-Bertani medium containing 100 mg/ml ampicillin and 30 mg/ml chloramphenicol at 37°C until the *D*~600~ value of the culture reached 0.7. IPTG (final concentration, 1 mM) was added to the cell culture to initiate recombinant protein overexpression. ^15^N-labelled and ^15^N/^13^C-labelled crammer samples were obtained from *E. coli* cultures incubated in M9 medium containing (1 g/l) ^15^NH~4~Cl and/or (2 g/l) \[^13^C\]glucose/^15^NH~4~Cl (Cambridge Isotope Laboratories) \[[@B29]\]. Whole cells were lysed with glacial acetic acid and centrifuged at 30700 **g** for 20 min at 4°C to remove the cell debris. The supernatant was dialysed against MilliQ water, and the precipitate was removed by centrifugation (30700 **g** for 10 min at 4°C). Recombinant crammer was purified by an 1100 Series RP-HPLC system (Agilent Technologies) using a C~18~ semi-preparative column (Nacalai). A linear water/acetonitrile gradient (29--37%) was used for protein separation, and purified protein fractions were characterized by an Autoflex III MALDI--TOF (matrix-assisted laser-desorption ionization--time-of-flight) mass spectrometer (Bruker Daltonics). Protein concentrations were determined using the Protein Assay reagents (Bio-Rad Laboratories) and bovine serum albumin of known concentrations as the calibration standards.

Characterization of the oligomeric states of crammer
----------------------------------------------------

Purified crammer (\~1 mg) was dissolved in buffers of varying pH values \[50 mM citric acid-sodium phosphate (pH 3.0--5.0), or 50 mM Tris/HCl (pH 6.0--8.0)\] for SEC (size-exclusion chromatography) analysis. The protein samples were loaded on to a 16/60 Superdex 75 pg column connected to an FPLC system (AKTAprime, Amersham Biosciences). To identify the oligomeric state of crammer *in vivo*, crammer was extracted from the heads of wild-type *D. melanogaster*, which were frozen in liquid nitrogen and detached from the fly bodies by vigorously shaking with pre-chilled 25- and 40-mesh sieves. The frozen heads were pulverized and suspended in 50 mM sodium acetate (pH 5.0), containing 1 mM EDTA, 0.1% Triton X-100 and 0.5 mM sodium azide \[[@B15],[@B30]\]. A polyclonal antibody against crammer (LTK BioLaboratories) was used to probe the oligomeric state of crammer.

Spectroscopic characterization of crammer
-----------------------------------------

Far-UV CD spectra were acquired using an Aviv CD spectrometer (Model 202, Aviv Biomedical). Wild-type crammer and C72S were buffered in 10 mM citric acid-sodium phosphate (pH 2.0--12.0) and the protein concentrations were set to 30 μM. The far-UV CD spectra were recorded at 20°C with a wavelength range between 260 and 190 nm, using a 1-mm path length cuvette. The helical contents of the samples were estimated using the CDNN software \[[@B31]\]. Thermal denaturation of crammer was carried out by recording a series of CD spectra from 4°C to 96°C, with an increment of 2°C. Intrinsic fluorescence of C72S (0.02 mg/ml) were recorded as a function of pH using a fluorimeter (F-7000, Hitachi) between 290 and 400 nm (λ~ex~=280 nm). For ANS fluorescence measurements as a function of pH values, the protein concentrations were 30 μM and that of ANS was 20 μM. The wavelength range was set to 385--600 nm (λ~ex~=365 nm).

NMR spectroscopy
----------------

Uniformly ^13^C/^15^N-labelled crammer (0.3 mM) was buffered in 10 mM citric acid-sodium phosphate containing 10% (v/v) ^2^H~2~O. The pH values of the samples were adjusted prior to NMR measurements at 25°C using AVANCE NMR spectrometers (Bruker Spectrospin) operating at ^1^H Larmor frequencies of 500 or 600 MHz, and a Varian INOVA NMR spectrometer equipped with a cryogenic probe head and operating at the ^1^H Larmor frequency of 700 MHz. The spectra were processed using TopSpin (Bruker Spectrospin), NMRPipe \[[@B32]\] and Sparky (T. D. Goddard and D. G. Kneller, University of California, San Francisco). ^1^H, ^13^C and ^15^N backbone and side-chain resonance assignments for spectra of crammer at pH 3.0 and pH 6.0 were obtained from a set of heteronuclear multidimensional NMR spectra \[[@B33],[@B34]\]. Secondary structure propensity was calculated using the SSP program \[[@B35]\] using the assigned ^13^Cα, ^13^Cβ and ^13^C\' chemical shifts. For the hetNOE \[heteronuclear NOE (nuclear Overhauser effect)\] experiments, ^1^H presaturation was achieved using a train of weak saturation pulse intervals during the 5-s recycle delay. The hetNOE value is defined as the ratio of the peak intensities recorded with and without ^1^H saturation, i.e. hetNOE=I^sat^/I^ref^, where I^sat^ is the peak intensity with saturation, and I^ref^ is the peak intensity without saturation \[[@B36]\]. To study the binding of crammer to *Drosophila* cathepsin L, the ^1^H-^15^N-HSQC (heteronuclear single quantum correlation) spectrum of ^15^N-labelled crammer and an excess of *Drosophila* cathepsin L in 10 mM citric acid/sodium phosphate buffer (pH 4.0) was recorded.

Solution structure determination
--------------------------------

^15^N- and ^13^C-edited NOESY-HSQC spectra of crammer were recorded at pH 6.0 to obtain distance constraints through manual assignments of the NOE cross-peaks ([Table 1](#T1){ref-type="table"}). The chemical shifts of the ^1^H^N^, ^15^N, ^1^Hα, ^13^Cα, ^13^Cβ and ^13^C\' resonances were used as the inputs for TALOS+ \[[@B37]\] to obtain backbone torsion angle constraints. CNS 1.1 was used for restrained molecular dynamics simulations to generate the solution structures \[[@B38]\]. The final ensemble consists of 11 lowest energy structures and was evaluated using the PROCHECK-NMR package \[[@B39]\] and Discovery Studio 2.0 (Accelrys). The solvent accessibility was calculated using Discovery Studio 2.0. PyMOL (<http://www.pymol.org>) was used for molecular visualization.

###### NMR constraints and structural statistics for C72S

RMSD, root mean square deviation.

  --------------------------------------------------- ---------------
  Distance constraints                                
   Total NOE                                          859
   Intraresidue                                       341
   Sequential (∣I--J∣=1)                              184
   Medium range (∣I--J∣≤4)                            78
   Long range (∣I--J∣\>4)                             61
   Hydrogen bond constraints                          61
   Total dihedral angle constraints                   134
   Φ                                                  67
   Ψ                                                  67
  RMSD (Å) with respect to the average structure      
   Well-defined regions (residues 8--49 and 52--74)   
    Backbone                                          0.4±0.1
    Heavy atoms                                       0.8±0.2
   All residues (residues 1--80)                      
    Backbone                                          1.9±0.4
    Heavy atoms                                       2.2±0.4
  Total energy after water refinement (kcal/mol)      −2700±100
  RMSD from idealized covalent geometry               
   Bonds (Å)                                          0.0153±0.0005
   Angles (°)                                         2.10±0.07
   Impropers (°)                                      2.6±0.1
  Ramachandran statistics                             
   Most favoured regions                              85.2%
   Additionally allowed regions                       13.6%
   Generously allowed regions                         1.1%
   Disallowed regions                                 0.0
  BioMagResBank accession code                        16719
  PDB code                                            2L95
  --------------------------------------------------- ---------------

Inhibition assay
----------------

The cathepsin-inhibition assay was carried out according to the procedure described by Comas et al. \[[@B5]\]. SEC was used to purify cathepsin from *Drosophila* heads. Each SEC fraction was subject to protease activity assays using Z-Phe-Arg-AMC as substrate (Calbiochem) \[[@B40],[@B41]\]. The amount of released AMC was measured by its fluorescence emission at 440 nm (λ~ex~=380 nm). The purified *Drosophila* cathepsin was identified using cathepsin B/L specific inhibitors \[[@B15],[@B42],[@B43]\] and the enzymatically active substance in the *Drosophila* head extract was mainly cathepsin L (Supplementary Figure S1 at <http://www.BiochemJ.org/bj/442/bj4420563add.htm>). Out of 6 g of *Drosophila* heads, we could obtain about 1 mg of active cathepsin L. We also constructed and expressed recombinant *Drosophila* cathepsin B using an *E. coli* expression system (described in detail in the Supplementary online data at <http://www.BiochemJ.org/bj/442/bj4420563add.htm>). The concentrations of active *Drosophila* cathepsins L and B were determined using E-64 \[[@B44]\]. For the inhibition assays, 70 mg of recombinant crammer was dissolved in 10 mM citric acid/sodium phosphate (pH 4.0) to yield a stock solution of 0.5 mM. Various concentrations of crammer taken from a stock solution were incubated with cathepsin (40 nM) in 100 mM sodium acetate (pH 5.0), containing 1 mM EDTA and 2 mM DTT. Z-Phe-Arg-AMC (18 μM) was then added to detect residual enzyme activity. Michaelis--Menten kinetics was used to determine the values of *K*~m~ and *V*~max~ of *Drosophila* cathepsin L in the presence or absence of crammer. The concentration of crammer was 10 nM. The non-linear curves were fit using KaleidaGraph (Synergy Software).

RESULTS
=======

Oligomeric state of crammer
---------------------------

Crammer has been reported to be either monomeric or dimeric \[[@B15]\], but the underlying mechanism for the monomer--dimer switch is hitherto unclear. We first examine the oligomeric state of crammer as a function of pH. SEC analysis reveals that crammer is predominately monomeric under acidic conditions, and it is dimeric at neutral and basic pH values ([Figure 1](#F1){ref-type="fig"}A). After incubation with excess 2-mercaptoethanol, the dimeric form of wild-type crammer is dissociated into monomers as shown by Tricine-SDS/PAGE ([Figure 1](#F1){ref-type="fig"}B). To confirm that the dimerization of crammer is a result of disulfide bond formation, we replace the only cysteine residue at position 72 with a serine, C72S, and indeed the dimeric form of crammer is no longer present in the SDS/PAGE gel ([Figures 1](#F1){ref-type="fig"}B and [1](#F1){ref-type="fig"}C). An Ellman assay \[[@B45],[@B46]\] shows that monomeric crammer has high free thiol content, but dimeric crammer does not (results not shown). Taken together, we conclude that dimeric crammer resulted from the formation of an intermolecular disulfide bond between crammer monomers. To investigate the oligomeric state of crammer *in vivo*, endogenous crammer was extracted from wild-type *Drosophila* heads and probed by Western blotting in the absence of 2-mercaptoethanol, and the results indicate that endogeneous crammer is monomeric, not dimeric, *in vivo* ([Figure 1](#F1){ref-type="fig"}D).

![Crammer dimerization as a function of pH\
(**A**) SEC is used to monitor the dimerization of crammer as a function of pH. Blue Dextran 2000 as the internal standard is eluted at the void volume. Molecular mass standards: 1, chymotrypsinogen A (25 kDa) and 2, RNase A (13.7 kDa). (**B**) 13% (w/v) Tricine-SDS/PAGE. Lane 1 contains molecular size markers (M). Lanes labelled monomer and dimer are HPLC-purified proteins, and the proteins contained in last two lanes are as labelled in the Figure. β-ME, 2-mercaptoethanol. (**C**) The results from SEC and Tricine-SDS/PAGE suggest that C72S at neutral pH exists in a monomeric form. (**D**) Crammer extracted from *Drosophila* heads is monomeric in the absence of 2-mercaptoethanol. The control lane labelled 'crammer' contains the recombinant protein, which exists as both monomer and dimer as visualized by the antibody against crammer. In (**B**) and (**D**) the molecular mass is given in kDa on the left-hand side. AU, arbitrary unit.](bic833i001){#F1}

Inhibitory assay
----------------

Deshapriya et al. \[[@B15]\] reported that both monomeric and dimeric crammer exhibit protease-inhibitory activity. To allow comparison of their results with those of the present study, recombinant crammer was incubated with *Drosophila* cathepsin L purified from fly head extracts to examine the enzyme activity ([Figure 2](#F2){ref-type="fig"}A) following the protocol reported by Comas et al. \[[@B5]\]. The ZFR-AMC enzymatic assay indicates that only monomeric, not dimeric, crammer exhibits inhibitory activity against *Drosophila* cathepsin L. The inhibition of cathepsin L, monitored by fluorescence, gives a linear plot as a function of time (Supplementary Figure S2 at <http://www.BiochemJ.org/bj/442/bj4420563add.htm>) and a Dixon plot is used to determine the enzyme-inhibitor inhibition constant (*K*~i~) \[[@B5],[@B9],[@B15]\]. The *K*~i~ value for monomeric crammer is 1.36±0.67 nM ([Figure 2](#F2){ref-type="fig"}B), which is comparable with those that have been reported for other strong cysteine protease inhibitors \[[@B9],[@B13],[@B15]\]. Additionally, recombinant wild-type crammer \[[@B5]\] and C72S in their monomeric forms also exhibit inhibitory activities against human cathepsin L (results not shown). Michaelis--Menten analysis reveals that the addition of crammer increases the Michaelis constant (*K*~m~) of *Drosophila* cathepsin L from 3.85 μM to 20.06 μM without affecting the *V*~max~ value (0.006 min^−1^) ([Figure 2](#F2){ref-type="fig"}C), which is a hallmark of competitive inhibition \[[@B47]\]. In summary, monomeric crammer is a strong competitive inhibitor that blocks the cathepsin substrate-binding site.

![Inhibitory activity of crammer against *Drosophila* cathepsin L\
(**A**) Plot of the initial rate (*V*~0~) compared with crammer concentration. Monomeric crammer markedly inhibits *Drosophila* cathepsin L. (**B**) Dixon plot analysis of inhibition of *Drosophila* cathepsin L. This analysis is used to determine the inhibition constant (*K*~i~) of the monomeric crammer. (**C**) Michaelis--Menten kinetics. Lineweaver--Burk analysis is utilized to determine kinetic parameters for *Drosophila* cathepsin L inhibition. The *K*~m~ value for cathepsin L increases in the presence of crammer, whereas the *V*~max~ value is unchanged.](bic833i002){#F2}

Structural characterization
---------------------------

We first employed far-UV CD spectroscopy to examine the structure of crammer. The far-UV CD spectrum of crammer at pH 7.0 exhibits a strong signal at 222 nm, corresponding to an α-helical content of 63±4%; crammer is less helical at pH 4.0 (34±4%; [Figure 3](#F3){ref-type="fig"}A). C72S appears to be slightly less helical than wild-type crammer at pH 7.0 (54±3%), but its α-helical content is similar to that of crammer at pH 4.0 (33±1%). When subject to thermal unfolding, crammer unfolds more cooperatively at pH 7.0 than it does at pH 4.0 ([Figure 3](#F3){ref-type="fig"}A, inset) \[[@B48]\]. Interestingly, the secondary structure of C72S is less sensitive to pH ([Figure 3](#F3){ref-type="fig"}A). For both wild-type and C72S, the ANS fluorescence negatively correlates with the CD signal at 222 nm as a function of pH, (Supplementary Figure S3 at <http://www.BiochemJ.org/bj/442/bj4420563add.htm>), indicating that both proteins partially unfold under acidic conditions.

![Spectral properties of crammer\
(**A**) Far-UV CD of crammer at various solution pH values and temperature. WT, wild-type. Inset: thermal denaturation of crammer and C72S monitored by CD at 208 nm. (**B**) The spectral properties of C72S as a function of pH monitored by far-UV CD and intrinsic fluorescence spectroscopy and ANS binding.](bic833i003){#F3}

We have employed far-UV CD, intrinsic tryptophan fluorescence and ANS-binding fluorescence spectroscopy to systematically monitor the folding of C72S as a function of pH ([Figure 3](#F3){ref-type="fig"}B). The far-UV CD signal at 222 nm follows a bell-shaped distribution with a maximum plateau between pH 5 and 8 flanked by significant decreases at lower and higher pH values, suggesting that α-helix formation is associated with salt-bridge formation \[[@B49]\]. At neutral pH, most ionizable residues should be ionized, rendering salt-bridge formation more favourable. At high acidic or basic pH values, salt bridges are less likely to form due to overall protonation and deprotonation respectively \[[@B49]\]. It is noteworthy that that we observe blue shift of the intrinsic fluorescence of C72S on increasing pH values (results not shown), indicating that the local environments of the aromatic groups become more hydrophobic as a result of well-defined hydrophobic core formation at neutral pH values \[[@B7],[@B50]\]. This finding is corroborated by the ANS data, which probe the extent to which hydrophobic regions are exposed ([Figure 3](#F3){ref-type="fig"}B) \[[@B7],[@B50]\]. At acidic pH values, ANS binds strongly to C72S, with fluorescent intensity peaking at pH 4.0. In the same assay, the fluorescence signal is lost at neutral pH, indicating the formation of a well-defined tertiary structure. Collectively, we conclude that crammer retains significant amount of helical structures under acidic conditions, but lacks a well-defined hydrophobic core as shown by the loss of cooperativity under thermal unfolding. This is good evidence to suggest that crammer is in a molten globular state under acidic conditions \[[@B51],[@B52]\].

Protein folding
---------------

In order to obtain structural insight into the structural transition of crammer at a residue-specific level, high-resolution NMR spectroscopy was employed to investigate the solution structure of crammer. We have carried out a pH titration for C72S by recording a series of ^1^H-^15^N HSQC spectra at different pH values ([Figure 4](#F4){ref-type="fig"}A and Supplementary Figure S4 at <http://www.BiochemJ.org/bj/442/bj4420563add.htm>). C72S exhibits poorly dispersed cross-peaks at pH 3.0 and 4.0, under which conditions C72S is predominantly molten globular. The observed resonances substantially broadened at pH 5.0. At pH values of 6.0 or higher, a new set of well-dispersed cross-peaks emerge, indicating the formation of a well-defined tertiary structure upon increase in pH, which is consistent with the global analysis by far-UV CD, intrinsic tryptophan fluorescence and ANS binding ([Figure 3](#F3){ref-type="fig"}).

![^1^H-^15^N-HSQC Spectra\
(**A**) ^1^H-^15^N-HSQC spectra of C72S as a function of pH. The assigned cross-peaks for C72S at pH 3.0 and pH 6.0 are labelled in the Figure. The inset shows an expanded view of part of the spectrum. (**B**) Secondary structure propensity and hetNOEs of C72S residues. Upper panel: secondary structure propensity (SSP) compared with C72S residue number. Red line, pH 3.0; black bars, pH 6.0. Positive values indicate α-helical propensity, and negative values indicate β-strand propensity. Lower panel: hetNOE values used to investigate the femtosecond-to-picosecond dynamics of C72S. Residues in folded regions have larger hetNOE values. The α-helical regions and the salt bridges are depicted schematically at the top of the Figure. (**C**) ^1^H-^15^N-HSQC spectra of wild-type (WT) crammer (pH 4.0) in the absence (black) or presence of *Drosophila* cathepsin L (red). (**D**) The spectra of the *Drosophila* cathepsin L/crammer complex (red) and C72S (blue). The C72S cross-peaks are labelled.](bic833i004){#F4}

We have assigned the backbone resonances of C72S (H^N^, Cα, Cβ, C\' and N) at pH 3.0 to examine the solution structure of crammer in detail \[BMRB (BioMagResBank) accession number 17367\]. Although the far-UV CD and intrinsic fluorescence spectra as well as the chemical shift dispersions in the ^1^H-^15^N HSQC spectrum all indicate that C72S is largely unfolded at pH 4.0 and below, the secondary chemical shifts of the Cα, Cβ, and C\' nuclei at pH 3.0 reflect a significant proportion of the molecule, particularly those in the N-terminal region, which exhibit substantial residual helical content ([Figure 4](#F4){ref-type="fig"}B). Interestingly, α2 shifts significantly from residues 22--48 (pH 6.0) to 18--42 (pH 3.0), thus resulting in the connection of α2 with α1 to form a long stretch of α-helix at pH 3.0. We have also measured the ^1^H-^15^N hetNOEs of C72S at pH 6.0 and pH 3.0 to probe fast backbone dynamics on the femtosecond to picosecond timescale ([Figure 4](#F4){ref-type="fig"}B) \[[@B36]\]. The overall hetNOE values are higher at pH 6.0 than those at pH 3.0, with average values of 0.72±0.05 and 0.34±0.02 respectively, indicating that the backbone conformation C72S is much more flexible, i.e. disordered, at pH 3.0, whereas at pH 6.0 the overall structure of C72S is compact and well defined. Despite the loss of compact hydrophobic core, the N-terminal region of C72S, especially α1 and the first half of α2, exhibits relatively higher hetNOE values (\>0.6) that are comparable with those observed at pH 6.0. Taken together, the NMR data indicate that C72S retains a substantial amount of helical structure at acidic pH despite an ill-defined hydrophobic core ([Figure 3](#F3){ref-type="fig"}B), further supporting our hypothesis that C72S is in a molten globular state under acidic conditions \[[@B53]\].

Intriguingly, although crammer is largely disordered at pH 4.0, the addition of cathepsin L purified from *Drosophila* head extract induces a molten globule-to-ordered structure transition as evidenced by the emergence of well-dispersed ^1^H-^15^N HSQC resonances ([Figures 4](#F4){ref-type="fig"}C and [4](#F4){ref-type="fig"}D). The chemical shifts of these cross-peaks are very similar to those of C72S at pH 6.0 ([Figure 4](#F4){ref-type="fig"}D), indicating that the solution structure of monomeric crammer C72S at pH 6.0 resembles that of cathepsin L-bound (activated) crammer at pH 4.0. We therefore use C72S at pH 6.0 as a mimic of cathepsin L-bounded crammer for detailed structural elucidation in the following section ([Table 1](#T1){ref-type="table"}).

Solution structure of C72S
--------------------------

We have obtained near complete backbone assignments of C72S except for those of Glu^8^, Pro^65^ and Val^76^--Asn^79^ (\>91% of all the expected H^N^, Cα, Cβ, C\' and N resonances). These unassigned residues all lay in the loop regions that are inherently flexible. The corresponding resonances are broadened beyond detection, which we attribute to the result of solvent exchange. The NMR chemical shift assignments of C72S have been deposited in the BMRB under accession number 16719. Using ^13^C/^15^N-edited NOESY spectra and backbone torsion angle restraints, we have determined the solution structure of C72S ([Figure 5](#F5){ref-type="fig"}A and [Table 1](#T1){ref-type="table"}) which has been deposited in the PDB (PDB code 2L95).

![Solution structure of C72S\
(**A**) Stereo view of eleven lowest-energy structures that are superpositioned on their backbone atoms (N, Cα and C\'). The helices α1, α2, α3 and α4 are labelled. The consensus sequence is shown at the top of the Figure, with the helical regions indicated. (**B**) Structure of human procathepsin L (PDB code 1CS8). The proregion is shown in ribbon representation. (**C**) The crammer residues involved in salt bridges are shown as ball-and-stick representation in the inset. (**D**) NOE cross-peaks for the charged side-chains that are involved in salt-bridge formation. (**E**) The aromatic residues in C72S are shown in spheres to indicate the hydrophobic core packing. The protein surface is shown in white.](bic833i005){#F5}

The solution structure of C72S contains four α-helices \[Asp^6^--Phe^16^ (α1), Ala^22^--Lys^48^ (α2), His^59^--Ala^61^ (α3) and Pro^65^--Arg^71^ (α4)\] with α2 serving as the core structure that appears to maintain the overall tertiary structure ([Figure 5](#F5){ref-type="fig"}A). The three-dimensional fold of crammer is very similar to that of the proregion of procathepsin L ([Figure 5](#F5){ref-type="fig"}B) \[[@B54]\]. Structural alignment of the two gives a moderate pairwise positional root mean squared deviation of 4.09 Å (1 Å=0.1 nm) for the Cα atoms within the secondary structure elements. The deviation is largely due to the result of different relative orientations of the individual α-helices ([Figure 5](#F5){ref-type="fig"}A).

There are two salt bridges that connect α1 and α2 (Asp^6^--Arg^29^ and Glu^8^--Lys^36^), and two that connect α2 and α4 (Glu^24^--Arg^28^ and Arg^28^--Glu^67^ ([Figure 5](#F5){ref-type="fig"}C). Their presence is confirmed by long-range NOEs between their respective side-chains ([Figure 5](#F5){ref-type="fig"}D). The ERFNIN motif is located in α2 and is surrounded by α1, α3, α4 and loop 2, which is a relatively long loop. As ERFNIN is located in the central region of the core structure, it may be an important folding element. Also important for folding are six well-conserved aromatic residues (Trp^9^, Tyr^12^, Phe^16^, Tyr^20^, Tyr^32^ and Phe^68^) that form a small hydrophobic core for structure stabilization ([Figure 5](#F5){ref-type="fig"}E).

To examine the importance of these aromatic residues in enzyme inhibition, we first constructed recombinant *Drosophila* cathepsins B and L (see the Supplementary online data). Recombinant cathepsin L could not be expressed despite the use of several expression vectors and *E. coli* strains (results not shown). We therefore focused on the enzymatic kinetics of cathepsin B inhibition by different concentrations of crammer ([Figure 6](#F6){ref-type="fig"}A). On the basis of non-linear regression analysis, the *k*~obs~ values exhibit a linear relationship with respect to crammer concentrations ([Figure 6](#F6){ref-type="fig"}B), implying a single-step, reversible and slow-binding inhibition mechanism \[[@B15],[@B55]\]. Individual alanine replacements of these aromatic residues decrease the inhibitory ability ([Figure 6](#F6){ref-type="fig"}C and [Table 2](#T2){ref-type="table"}). Wild-type crammer displays a maximal *Drosophila* cathepsin B inhibition with a *K*~i~ value of 0.79±0.35 μM. In contrast, W9A, Y12A, and Y20A exhibit weak or medium inhibition activities. The removal of these aromatic side chains are expected to perturb the hydrophobic core, and the loss of structural integrity in turn diminishes the inhibitory activities against cathepsin B. This is particularly pronounced for W9A ([Figures 5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"}), lending support to the importance of these aromatic residues in protein folding. Finally, Ser^72^, located in the flexible C-terminal region, is more than 95% solvent accessible. Cys^72^ in crammer is also probably highly exposed, which would allow for intermolecular disulfide bond formation.

###### Cathepsin B inhibitor inhibition constants

The *K*~i~ values are determined by the *V*~0~ and *V*~s~ values. N.D., not determined.

  Enzyme                     Crammer        W9A    Y12A            F16A           Y20A           C72S
  -------------------------- -------------- ------ --------------- -------------- -------------- --------------
  Cathepsin B *K*~i~ value   0.79±0.35 μM   N.D.   18.94±2.24 μM   2.26±0.23 μM   5.40±1.25 μM   1.87±0.63 μM

![Inhibitory activities of crammer and its mutants against *Drosophila* cathepsin B\
(**A**) Progress curves for the cathepsin B inhibition by different concentrations of crammer are non-linear as a function of time, implying a typical slow-binding inhibition. The observed fluorescence signals are fitted using the equation, \[*P*\]=*V*~s~×*t*+(*V*~0~--*V*~s~)×\[1−exp(−*k*~obs~×*t*)\]/*k*~obs~ \[[@B15],[@B55]\], where *P* is the amount of product formed at time *t*, *V*~0~ and *V*~s~ are the initial and steady-state velocities respectively, and *k*~obs~ is the rate constant for inhibition. (**B**) Plot of *k*~obs~ compared with crammer concentrations for the inhibition of cathepsin B. On the basis of a regression analysis \[[@B15],[@B55]\], the *K*~i~ values can be obtained. (**C**) Plots of the initial rates of fluorescence increase as a function of inhibitor (crammer variants) concentrations. The conserved aromatic residues are replaced with alanine to clarify their potential roles in cathepsin B inhibition.](bic833i006){#F6}

DISCUSSION
==========

Using Western blotting, we have established that endogenous crammer (isolated from fruit fly head) is monomeric *in vivo* ([Figure 1](#F1){ref-type="fig"}D). Crammer contains a lysosomal-localization motif (YKX~4~KXY) that probably targets crammer into the lysosome, a highly acidic (\<pH 5.0) cellular compartment where crammer is expected to be predominantly monomeric ([Figure 1](#F1){ref-type="fig"}A). Although Deshapriya et al. \[[@B15]\] reported that both monomeric and dimeric forms of crammer can inactivate cathepsin, our inhibitory assay has shown that only monomeric, not dimeric, crammer is a strong natural inhibitor (nanomolar range) of cathepsin L. Under acidic conditions, monomeric crammer contains a substantial amount of helical conformation, but lacks a compact hydrophobic core ([Figures 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}A), indicating that crammer is a molten globule under acidic conditions. When bound to cathepsin L, however, crammer adopts an ordered structure that gives rise to well-dispersed NMR resonances which highly resemble those of C72S at pH 6.0 ([Figures 4](#F4){ref-type="fig"}C and [4](#F4){ref-type="fig"}D). Supported by the spectral similarity, we therefore use C72S at pH 6.0 to mimic the cathepsin L-bound form of wild-type crammer at physiological, acidic conditions, for detailed structural elucidations.

Despite the reports of several cysteine protease structures \[[@B56],[@B57]\], there is hitherto no structural information of protease proregions in isolation and that of propeptide-like protease inhibitors. The solution structure of C72S is the first high-resolution structure for a propeptide-like protease inhibitor. Indeed, the structure of C72S resembles that of the human cathepsin L proregion (PDB code 1CS8; [Figure 5](#F5){ref-type="fig"}B) \[[@B54]\]. The proregion C-terminal residues of procathepsin L blocks the cathepsin active site \[[@B54]\], as do those of crammer. The two structures also share the same topology; however, the sequence composition and chain length between the two proteins are very different, as reflected by structural differences for α3 and the N- and C-termini. C72S has an additional helical segment (α3), encompassing residues 59--61, that is absent in the proregion of human cathepsin L. In particular, the C-terminal tail of the proregion is longer and is free of cysteine.

Human cathepsins B and L have been associated with certain neurodegenerative diseases, e.g. Parkinson\'s disease \[[@B58]\]. In the fruit fly, the overexpression of crammer impairs LTM \[[@B5],[@B6]\], providing evidence of causal relationship between cysteine protease activities and neurophysiology in humans and flies. In general, activation of human cathepsin requires cleavage of its proregion at acidic pH \[[@B59]\]. When cleaved, the proregion exists as a molten globule \[[@B60]\], as we have shown here for crammer under acidic conditions. Nonetheless, the cleaved proregion does not inactivate cathepsin \[[@B61]\]. Although much experimental work is required to further establish the activation mechanism of *Drosophila* cathepsin, our data and that of others have suggested that human and *Drosophila* cathepsins may be activated by the same mechanism.

Our bioinformatic analysis suggests that crammer is localized in the lysosome. Although both crammer and the cleaved proregion of human cathepsin share molten globule-like structural features under acidic conditions *in vitro*, crammer is a strong inhibitor of cathepsin under acidic conditions, whereas the proregion is not \[[@B61]\]. Importantly, the tight binding of crammer to cathepsin is associated with a molten globule-to-ordered structure transition. It remains to be seen if such a structural transition occurs when other propeptide-like protease inhibitors bind to their targets. This structural transition is also regulated by pH. Once crammer is in other organelles with higher pH values, crammer probably presents as an inactive dimer against cathepsin. Hence, the switch from monomeric to dimeric crammer is probably an alternative mechanism for the cathepsin regulation. This pH-mediated regulation is also observed in other proteins \[[@B62]\]. However, the detailed molecular mechanism of this regulation in crammer requires further investigation.

Online data
===========

###### Supplementary data
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